Transmission electron micrograph showing hepatitis B virus particles (colored orange). The Johns Hopkins Medicine-led ...

With NIH funding, the group will pursue research and patient care approaches for a disease that affects more than 250 million people around the globe ...

A new research study shows that hepatitis B vaccination rates among newborns in the U.S. declined by more than 10 percent ...

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group ...

A research team from Indonesia identified the distribution of hepatitis B virus subgenotype and basal core promoter mutations among patients with HBV-associated liver disease in Indonesia. They found ...

Newborn hepatitis B virus vaccination rates in the U.S. decreased by over 10 percentage points in the last 2 years after ...

Hepatitis B (HBV) is a viral infection that affects the liver by causing inflammation. This can lead to permanent scarring, what medical professionals call liver fibrosis or cirrhosis. Most hepatitis ...

There is currently no known cure for hepatitis B virus (HBV) infection, and HBV remains a major public health burden in the United States. The US Department of Health and Human Services has ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies ...

The first Notice of Allowance relates to U.S. Patent Application No. 19/347,136, titled "Engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome." The ...

Hepatitis B is one of the most widespread viral infections in the world, with hundreds of millions of people living with it today. Caused by the hepatitis B virus (HBV), this condition primarily ...